SCOPUS 정보 검색 플랫폼

Volumn 33, Issue 2, 2001, Pages 433-438

Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C

(15) Reddy, K Rajender a Wright, Teresa L b Pockros, Paul J c Shiffman, Mitchell d Everson, Gregory e Reindollar, Robert f Fried, Michael W g,m Purdum, Preston P h Jensen, Donald i Smith, Coleman j Lee, William M k Boyer, Thomas D g Lin, Amy l Pedder, Simon l DePamphilis, Jean l

a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE (United States)

b VETERANS AFFAIRS MEDICAL CENTER (United States)

c SCRIPPS CLINIC (United States)

d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE (United States)

e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE (United States)

f Carolinas Center for Liver Disease (United States)

g EMORY UNIVERSITY SCHOOL OF MEDICINE (United States)

h Charlotte GI/Liver Disease Clinic (United States)

i RUSH UNIVERSITY MEDICAL CENTER (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ALOPECIA; ARTHRALGIA; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FATIGUE; FEMALE; FEVER; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RIGOR; VIRUS REPLICATION; VOMITING;

EID: 17744389383 PISSN: 02709139 EISSN: None Source Type: Journal
DOI: 10.1053/jhep.2001.21747 Document Type: Article

Times cited : (352)

References (21)

1
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶ Goodman, Z.C.⁷

2
- 0032585237
- Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niederau, C.⁴ Minuk, G.S.⁵ Ideo, G.⁶ Bain, V.⁷

3
- 0032875997
- Comparison of thrice weekly vs daily leucocyte interferon-alpha therapy for chronic hepatitis C
- (1999) J Viral Hepat , vol.6 , pp. 321-327
- Chemello, L.¹ Cavalletto, L.² Bernardinello, E.³ Boccato, S.⁴ Casarin, P.⁵ Cavinato, F.⁶ Urban, F.⁷

4
- 0025203837
- Clinical pharmacokinetics of interferons
- (1990) Clin Pharmacokinet , vol.19 , pp. 390-399
- Wills, R.J.¹

5
- 0001369293
- Single-dose safety/tolerability and pharmacokinetic/pharmacodynamics (PK/PD) following administration of ascending subcutaneous doses of pegylated-interferon (PEG-IFN) and interferon α-2a (IFNα-2a) to healthy subjects
- (1998) Hepatology , pp. 702
- Xu, Z.-X.¹ Patel, I.² Joubert, P.³

6
- 0033928514
- Controlled-release, pegylation, liposomal formulations: New mechanisms in the delivery of injectable drugs
- (2000) Ann Pharmacother , vol.34 , pp. 915-923
- Reddy, K.R.¹

7
- 0029039362
- Histological grading and staging of chronic hepatitis
- (1995) J Hepatol , vol.22 , pp. 696-699
- Ishak, K.¹ Baptista, A.² Bianchi, L.³ Callea, F.⁴ De Groote, J.⁵ Gudat, F.⁶ Denk, H.⁷

8
- 0032796827
- Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test
- (1999) J Clin Microbiol , vol.37 , pp. 2625-2630
- Germer, J.J.¹ Rys, P.N.² Thorvilson, J.N.³ Persing, D.H.⁴

9
- 0030885469
- Factors predictive of a beneficial response to therapy of hepatitis C
- (1997) Hepatology , vol.26 , pp. 122S-127S
- Davis, G.L.¹ Lau, J.Y.²

10
- 0029084933
- Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C
- (1995) HEPATOLOGY , vol.22 , pp. 1050-1056
- Martinot-Peignoux, M.¹ Marcellin, P.² Poteau, M.³ Castelnau, C.⁴ Boyer, N.⁵ Poliquin, M.⁶ Degott, C.⁷

11
- 0028812140
- Hepatitis C virus type 1b (II) infection in France and Italy
- (1995) Ann Intern Med , vol.122 , pp. 161-168
- Nousbaum, J.B.¹ Pol, S.² Nalpas, B.³ Landais, P.⁴ Berthelot, P.⁵ Brechot, C.⁶

12
- 84984533465
- Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C
- (1996) Gastroenterology , vol.111 , pp. 1307-1312
- Lai, M.Y.¹ Kao, J.H.² Yang, P.M.³ Wang, J.T.⁴ Chen, P.J.⁵ Chan, K.W.⁶ Chu, J.S.⁷

13
- 12644299637
- Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C
- (1997) HEPATOLOGY , vol.26 , pp. 780-785
- Shiffman, M.L.¹ Hofmann, C.M.² Thompson, E.B.³ Ferreira-Gonzalez, A.⁴ Contos, M.J.⁵ Koshy, A.⁶ Luketic, V.A.⁷

14
- 0031816759
- Viral kinetics can predict early response to alpha-interferon in chronic hepatitis C
- (1998) Liver , vol.18 , pp. 191-495
- Walsh, K.M.¹ Good, T.² Cameron, S.³ Thorburn, D.⁴ McCruden, E.A.⁵ Mills, P.R.⁶ Morris, A.J.⁷

15
- 0030985850
- Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C
- (1997) J Gastroenterol Hepatol , vol.12 , pp. 468-472
- Kakumu, S.¹ Aiyama, T.² Okumura, A.³ Iwata, K.⁴ Ishikawa, T.⁵ Yoshioka, K.⁶

16
- 0031924165
- Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa
- (1998) Hepatology , vol.27 , pp. 1149-1156
- Zeuzem, S.¹ Lee, J.H.² Franke, A.³ Rüster, B.⁴ Prümmer, O.⁵ Herrmann, G.⁶ Roth, W.K.⁷

17
- 85008320429
- Roferon-A [package insert] Nutley, NJ: Hoffmann-La Roche lnc
- (1999)

18
- 85008329907
- Intron-A [package insert] Kenilworth, NJ: Schering Corporation
- (1998)

19
- 0000215852
- Phase I study of pegylated-interferon α-2A (PEGA-SYS™) in patients With chronic myelogenous leukemia (CML)
- (1999) Blood , pp. 530
- Talpaz, M.¹ O'Brien, S.² Cortes, J.³ Giles, F.⁴ Rittweger, K.⁵ Hooftman, L.⁶ Rakhit, A.⁷ Kantarjian, H.⁸

20
- 0028316163
- Adverse effects and drug interactions of clinical importance with antiviral drugs
- (1994) Drug Safety , vol.10 , pp. 281-291
- Morris, D.J.¹

21
- 0000030786
- Multinational evaluation of the efficacy and safety of once-weekly peginterferon α-2a (PEG-IFN) in patients with chronic hepatitis C (CHC) with compensated cirrhosis
- (1999) Hepatology , vol.30 , pp. 316A
- Heathcote, E.J.¹ Shiffman, M.L.² Cooksley, G.³ Dusheiko, G.⁴ Lee, S.S.⁵ Balart, L.⁶ Reindollar, R.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.